South Korea signs deals with Pfizer and Janssen to import Covid-19 vaccines
South Korean Prime Minister Chung Se-kyun said in a briefing on Thursday that South Korea has signed contracts with Pfizer’s pharmaceutical company Janssen and Johnson & Johnson to import Covid-19 vaccines.
According to the contract, South Korea will import doses of 6 million people from Janssen, an increase of 2 million from the advertiser in early December. Chung added that the vaccination with Janssen doses will begin in the second quarter of 2021.
Chung said that South Korea will also import vaccine doses for ten million people from Pfizer in the third quarter of 2021. Chung added that the government is doing its best to introduce the Pfizer vaccine in the second quarter of next year.
Earlier, South Korea announced that it had signed a contract with vaccine development company AstraZeneca to import vaccines for 10 million people starting in the first quarter of 2021. The government said it will also import vaccine doses for 10 million people from our state and additional doses for 10 million people. One million people through the Kovacs facility.
South Korea is home to about 52 million people.
Situation in South Korea: The East Asian country recorded 955 domestic cases and 30 imported cases of Covid-19 on Wednesday, of which 644 were from the Seoul metropolitan area, the Korea Disease Control and Prevention Agency said in a press release Thursday. An additional 17 deaths were reported on Wednesday.
The latest figures bring the total number of cases since the start of the epidemic to 53,533, including 756 deaths.
“Explorer. Devoted travel specialist. Web expert. Organizer. Social media geek. Coffee enthusiast. Extreme troublemaker. Food trailblazer. Total bacon buff.”